Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/8/17 → 10/9/25 |
Funding
- Trustees of Columbia University in the City of New York: $59,202.50
AAAP9506:A randomized phase II trial of fulvestrant with or without Ribociclib after progression on aromatase inhibition plus cyclin-dependent kinase 4/6 inhibition in patients with unresectable or metastatic hormone receptor positive....
- Baer, Lea (PI)
- Cohen, Jules A (CoPI)
- Stopeck, Alison (CoPI)
Project: Research